Fact CheckerSign in

NCT06864689Not yet recruitingEarly phase 1

Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.

Source: ClinicalTrials.gov · Last updated 4 Sept 2026

Brief summary (registry, in English)

The primary objective of this R34 proposal is to increase willingness for PrEP initiation and PrEP initiation among Black Women (BW) and increase willingness to prescribe/refer pre-exposure prophylaxis (PrEP) to CBW among healthcare providers (HCPs) in Houston/Harris County, a high priority Ending the HIV Epidemic (EHE) jurisdiction.

Status (registry)
Not yet recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
78 (estimated)
First submitted
13 Feb 2025
Start date
31 Oct 2026
Primary completion date
2 Aug 2027
Lead sponsor
The University of Texas Medical Branch, Galveston
Diseases
HIV
NCT number
NCT06864689

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 78
  • From 31 Oct 2026 to the primary completion date, 2 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Selection criteria for participation in pilot RCT.
  • Eligible participants in the category for Black Women (BW) must:
  • be a woman
  • be 18 years of age
  • have been sexually active with a man within the past 6 months
  • be fluent in English
  • have a phone or internet access
    • Eligible participants (i.e. PrEP-eligible BW) must not:
  • be unable to provide informed consent/assent for participation (i.e., have severe cognitive impairment hat would interfere with their ability to consent or understand study procedures)
  • have psychological distress that would prohibit them from participating in the study
  • be unable or unwilling to meet study requirements
  • be ineligible for PrEP
  • received a prescription for PrEP within 12 months6)be unable to fill out the evaluation independently
    • Eligible participants in the HCP category must:
  • be a credentialed HCP in Texas with privileges to prescribe and/or refer PrEP
  • BW must be a part of their patient pool at the clinical setting where they practice clinically
  • be fluent in English
  • have a phone or internet access
  • Live and/or practice medicine within a 60-mile radius of Houston/Harris County
    • Eligible HCP must not:
  • be unable to provide informed consent for participation (e.g. have severe cognitive impairment that would interfere with their ability to consent, or ability to understand study procedures
  • have psychological distress that would prohibit them from participating in the study
  • be unable or unwilling to meet study requirements
  • be unwilling to offer PrEP to BW patients
  • have prescribed or referred PrEP to BW within the last 12 months

Age in the registry: 18 years to 99 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas Medical Branch - Galveston
Coordinator of this site? Confirm its status
GalvestonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.